HMGB1 and Miyoshi myopathy: Thus, HMGB1 fulfills essential biomarker criteria, including biological plausibility, clinical relevance, accessibility through non-invasive sampling, and measurable correlation with disease status, underscoring its value in MM diagnosis and prognosis.